Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer
Daniel Carvajal‐Hausdorf(Clínica Alemana), David L. Rimm(Yale University)
Cited by 46
Related Papers
Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer
|JAMA Oncology|2015|834
PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer
|Cancer Immunology Research|2014|391
Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)
|Journal for ImmunoTherapy of Cancer|2019|195
Quantitative and pathologist-read comparison of the heterogeneity of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer
|Modern Pathology|2016|166
Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study
|Laboratory Investigation|2018|138